OGA and synucleinopathy: Pharmacological inhibition of OGA or OGT effectively alleviates or exacerbates α-syn aggregation, spreading, dopaminergic neuron degeneration, and neuroinflammation, which contribute to α-synucleinopathies in neurodegenerative diseases.